Company Overview - Founded in 2003 with a registered capital of 84.748746 million yuan [5] - Focuses on automotive injection molds and plastic components, providing comprehensive solutions [5] - Operates 5 wholly-owned subsidiaries, including locations in Thailand and Europe [5] Product and Client Base - Main products include interior and exterior injection molds for vehicles [6] - Clients include major automotive manufacturers like General Motors, Volkswagen, and Tesla [6] - The company has established a strong brand presence and is recognized as a key supplier in the automotive mold industry [10][11] Research and Development - R&D investment reached 28.3312 million yuan in 2024, accounting for 4.17% of revenue, a 15.34% increase from the previous year [7][8] - Achieved a total of 98 patents by the end of 2024, including 26 invention patents [8] - Developed several core technologies in injection mold and modified materials, maintaining a competitive edge [8][9] Financial Performance - In Q1 2025, revenue was 192 million yuan, a 37.20% year-on-year increase; net profit reached 13.9196 million yuan, up 5,738.82% [12] - The company’s order backlog for injection molds was valued at 980 million yuan, a 17.21% increase year-on-year [14] Production Capacity and Utilization - Current production capacity for molds is approximately 80% utilized, with expectations for growth in 2025 [14] - The Thailand facility is nearing full capacity, with significant orders from clients like BYD and Magna [16] Strategic Initiatives - The company is expanding into modified materials, with a projected annual capacity of 150,000 tons by the end of 2025 [9][27] - Focus on "mold-plastic integration" to enhance service offerings and reduce development costs for clients [29] Market Trends and Future Outlook - The Thai government aims for a 30% penetration rate of electric vehicles by 2030, providing growth opportunities for the company [18] - Anticipated revenue growth in the automotive parts sector, driven by increased production capacity and market demand [18] Risk Management - The impact of U.S. tariffs on the company is minimal, with only 3.93% of sales directed to the U.S. market [30]

| 证券代码：301022 | 证券简称：海泰科 | 公告编号：2025-065 | | --- | --- | --- | | 债券代码：123200 | 债券简称：海泰转债 | | 青岛海泰科模塑科技股份有限公司 关于使用暂时闲置募集资金进行现金管理到期赎回 并继续进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 青岛海泰科模塑科技股份有限公司（以下简称"公司"）于 2025 年 4 月 23 日 召开了第二届董事会第二十九次会议、第二届监事会第二十四次会议，审议通过了 《关于使用暂时闲置募集资金及自有资金进行现金管理的议案》，同意公司及全资 子公司在确保不影响募集资金投资项目建设、不影响正常生产经营及确保资金安全 的情况下，使用不超过人民币 35,000.00 万元的暂时闲置募集资金和不超过人民币 10,000.00 万元的自有资金进行现金管理，使用期限自董事会审议通过之日起 12 个 月内有效，上述额度可以由公司使用，亦可以由公司的全资子公司使用，但应予以 合并计算。本次额度生效后将覆盖前次授权额度，在前述额度和期限范围内，资金 ...

Company Overview - Founded in 2003 with a registered capital of 84.748746 million yuan [5] - Focuses on R&D, design, manufacturing, and sales of automotive injection molds and plastic components [5] - Operates five wholly-owned subsidiaries, including locations in Thailand and Europe [5] Product and Client Base - Main products include interior and exterior injection molds for vehicles [6] - Clients include major automotive manufacturers such as General Motors, Volkswagen, and various domestic brands [6] - Revenue from products for new energy vehicles reached 166 million yuan in 2024, a 126.21% increase year-on-year, accounting for 24.39% of total revenue [12] R&D and Innovation - R&D investment in 2024 was 28.3312 million yuan, representing 4.17% of revenue, a 15.34% increase from the previous year [8] - Total patents held reached 98 by the end of 2024, including 26 invention patents [8] - Developed multiple core technologies in injection molding, leading to competitive advantages in the industry [8] Market Position and Competitive Advantages - Recognized as a leading supplier in the automotive injection mold industry with a strong brand image [10] - Established long-term relationships with clients, enhancing customer loyalty and reducing risks [11] - Barriers to entry include technology, brand, management, and capital requirements, limiting competition from smaller firms [18] Future Growth Drivers - Anticipated growth in automotive injection mold production, with an expected output of around 1,000 sets annually post-2024 [23] - Expansion of plastic components business with a new factory in Thailand projected to generate an additional 100 million yuan in output [23] - High polymer new materials project expected to achieve annual sales of 1.745 billion yuan upon full production by 2027 [23] Export and Market Strategy - Export revenue accounted for 60.97% in 2024, with minimal impact from U.S. tariff policies due to strategic pricing [25] - Focus on high-value orders and international market expansion, particularly in Europe [19]

创业板股最新融资余额为3421.94亿元，环比减少6.92亿元，21只股融资余额环比增长超10%，融资余额 环比降幅超10%的有11只。 融资余额环比下降的个股有489只，其中，降幅超过10%的有11只。宏工科技融资余额降幅居首，最新 融资余额6294.88万元，环比下降26.73%；融资余额降幅较大的个股还有海泰科、鸿铭股份等，融资余 额分别下降了18.57%、17.65%。（数据宝） 融资余额降幅居前个股 | 代码 | 简称 | 最新融资余额(万 | 融资余额环比增减 | 收盘价 | 当日涨跌幅 | 所属行 | | --- | --- | --- | --- | --- | --- | --- | | | | 元） | （%） | （元） | （%） | 业 | | 301662 | 宏工科 | 6294.88 | -26.73 | 74.59 | -10.46 | 电力设 | | | 技 | | | | | 备 | | 301022 | 海泰科 | 4783.41 | -18.57 | 28.77 | -5.36 | 汽车 | | 301105 | 鸿铭股 | 1621.19 | -17.65 | 39 ...

| 证券代码：301022 | 证券简称：海泰科 | 公告编号：2025-063 | | --- | --- | --- | | 债券代码：123200 | 债券简称：海泰转债 | | 青岛海泰科模塑科技股份有限公司 2024 年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1.本次股东大会无增加、变更、否决议案的情形； 2.本次股东大会不涉及变更以往股东大会已通过的决议； 3.本次股东大会以现场投票和网络投票相结合的方式召开。 一、会议召开情况 1、会议召开时间： （1）现场会议时间：2025 年 5 月 22 日（星期四）下午 14:00。 （2）网络投票时间：2025 年 5 月 22 日（星期四），其中： ①通过深圳证券交易所系统进行网络投票的时间为 2025 年 5 月 22 日 9:15- 9:25，9:30—11:30，13:00—15:00； ②通过深圳证券交易所互联网投票系统进行网络投票的时间为 2025 年 5 月 22 日 9:15—15:00。 2、会议地点：山东省青岛市城阳区棘洪滩街道锦盛二路 66 ...

山东国曜琴岛（青岛）律师事务所 关于青岛海泰科模塑科技股份有限公司 2024 年度股东大会的法律意见书 致：青岛海泰科模塑科技股份有限公司 山东国曜琴岛（青岛）律师事务所（以下简称"本所"）接受公司的委托， 指派徐述律师、王瑗律师对公司 2024 年度股东大会（以下称"本次股东大会"） 的有关事项进行了审查，查阅了有关文件，并出席了公司于 2025 年 5 月 22 日下 午 14:00 在青岛市城阳区棘洪滩街道锦盛二路 66 号公司三楼会议室召开的本次 股东大会的现场会议。 作为公司的特聘常年法律顾问，本所律师依据本法律意见书出具日前已经发 生或存在的事实和《中华人民共和国公司法》（以下称"《公司法》"）、《中华人民 共和国证券法》（以下称"《证券法》"）、《上市公司股东会规则》等现行有效的法 律、法规和规范性文件以及《青岛海泰科模塑科技股份有限公司章程》（以下简 称"《公司章程》"）的有关规定出具本见证意见。 为出具本见证意见，本所律师审查了公司本次股东大会有关文件和资料，并 得到公司如下保证：公司已向本所律师提供了作为出具本见证意见所必须的材料， 所提供的原始材料、副本、复印件、说明等材料均符合真实、准 ...

| 证券代码：301022 | 证券简称：海泰科 | 公告编号：2025-062 | | --- | --- | --- | | 债券代码：123200 | 债券简称：海泰转债 | | 青岛海泰科模塑科技股份有限公司 关于使用暂时闲置募集资金进行现金管理到期赎回 并继续进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 青岛海泰科模塑科技股份有限公司（以下简称"公司"）于 2024 年 4 月 22 日 召开了第二届董事会第十九次会议、第二届监事会第十七次会议，审议通过了《关 于使用暂时闲置募集资金及自有资金进行现金管理的议案》，同意公司及全资子公 司在确保不影响募集资金投资项目建设、不影响正常生产经营及确保资金安全的情 况下，使用不超过人民币 36,000.00 万元的暂时闲置募集资金（含超募资金）和不 超过人民币 15,000.00 万元的自有资金进行现金管理，使用期限自股东大会审议通 过之日起 12 个月内有效，上述额度可以由公司使用，亦可以由公司的全资子公司 使用，但应予以合并计算。本次额度生效后将覆盖前次授权额度，在前述额度和期 ...

| 证券代码：301022 | 证券简称：海泰科 公告编号：2025-061 | | --- | --- | | 债券代码：123200 | 债券简称：海泰转债 | 青岛海泰科模塑科技股份有限公司 关于 5%以上股东减持计划时间届满暨实施情况的公告 股东刘奇保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述 或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 青岛海泰科模塑科技股份有限公司（以下简称"公司"）于 2025 年 1 月 15 日 在巨潮资讯网（http://www.cninfo.com.cn）披露了《关于持股 5%以上股东减持股份 的预披露公告》（公告编号：2025-004），公司 5%以上股东刘奇计划通过集中竞 价或大宗交易等方式减持公司股份不超过 847,570 股（占公司总股本比例 1.0000%）， 自上述公告披露之日起 15 个交易日后的 3 个月内（即 2025 年 2 月 13 日至 2025 年 5 月 12 日）实施。 近日，公司收到股东刘奇出具的《关于减持计划时间届满暨实施情况的告知 函》，现将相关情况公告如下： 一、股东减持情 ...

Group 1: Financial Performance - In 2024, the company achieved operating revenue of 67,885.20 million CNY, an increase of 18.59% year-on-year [3] - Revenue from products used in new energy vehicles reached 16,556.37 million CNY, up 126.21%, accounting for 24.39% of total revenue [3] - The net profit attributable to shareholders was 1,575.60 million CNY, a decrease of 32.34% compared to the previous year [3] Group 2: Order and Production Capacity - As of the end of 2024, the company had new injection mold orders worth 8.52 billion CNY, a year-on-year increase of 26.97% [5] - The company’s production capacity for molds in 2024 was approximately 1,000 sets, with an actual output of 735 sets, resulting in a capacity utilization rate of 73.5% [4] - By the end of 2024, the company had a backlog of injection mold orders worth 9.38 billion CNY, a 22.57% increase year-on-year [5] Group 3: Future Projects and Investments - The second phase of the Thailand factory is expected to be operational by August 2025, with an anticipated additional output value of around 100 million CNY [6] - The company plans to distribute cash dividends of 3 CNY per 10 shares, totaling 25,427,100 CNY, with a distribution ratio of 161.38% [6] - The company’s modified materials business is projected to reach a total capacity of 150,000 tons per year by the end of 2025 [12] Group 4: Research and Development - In 2024, the company invested 28,331.20 million CNY in R&D, accounting for 4.17% of operating revenue, a 15.34% increase year-on-year [10] - The company obtained a total of 29 patents in 2024, including 19 invention patents and 10 utility model patents [10] - The company has developed several core technologies, including micro-foaming injection molding technology and high-gloss PC+ABS plastic alloy technology [11][8] Group 5: Market Position and Strategy - The company maintains a strong order backlog and stable production operations, with a focus on sustainable development and shareholder returns [4][6] - The company’s foreign sales accounted for 60.97% of total revenue in 2024, with minimal impact from trade tensions due to a concentration of customers in Europe [13] - The company differentiates itself through a "molding and plastic integration" approach, providing comprehensive solutions from mold customization to raw material supply [15]

关于使用暂时闲置募集资金进行现金管理到期赎回 并继续进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 青岛海泰科模塑科技股份有限公司（以下简称"公司"）于 2024 年 4 月 22 日 召开了第二届董事会第十九次会议、第二届监事会第十七次会议，审议通过了《关 于使用暂时闲置募集资金及自有资金进行现金管理的议案》，同意公司及全资子公 司在确保不影响募集资金投资项目建设、不影响正常生产经营及确保资金安全的情 况下，使用不超过人民币 36,000.00 万元的暂时闲置募集资金（含超募资金）和不 超过人民币 15,000.00 万元的自有资金进行现金管理，使用期限自股东大会审议通 过之日起 12 个月内有效，上述额度可以由公司使用，亦可以由公司的全资子公司 使用，但应予以合并计算。本次额度生效后将覆盖前次授权额度，在前述额度和期 限范围内，资金可循环滚动使用。具体详见公司于 2024 年 4 月 23 日发布于巨潮资 讯网（www.cninfo.com.cn）的《关于使用暂时闲置募集资金及自有资金进行现金管 理的公告》（公告编号：2024-04 ...